View in EDS HTML Full Text PDF Full Text

AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.

Saved in:
Bibliographic Details
Title: AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.
Authors: van Laar, Jacob M.1 (AUTHOR) j.m.vanlaar@umcutrecht.nl, Lei, Alejhandra2 (AUTHOR), Safy‐Khan, Mary1 (AUTHOR), Almquist, Joachim3 (AUTHOR), Belfield, Graham4 (AUTHOR), Edman, Karl5 (AUTHOR), Öberg, Lisa6 (AUTHOR), Angermann, Bastian R.6 (AUTHOR), Dillmann, Inken4 (AUTHOR), Berntsson, Pia7 (AUTHOR), Etal, Damla4 (AUTHOR), Dainty, Ian7 (AUTHOR), Astbury, Carol8 (AUTHOR), Belvisi, Maria G.9,10 (AUTHOR), Nemes, Szilárd11 (AUTHOR), Platt, Adam12 (AUTHOR), Prothon, Susanne3 (AUTHOR), Samuelsson, Sara13 (AUTHOR), Svanberg, Petter14 (AUTHOR), Keen, Christina13 (AUTHOR)
Source: CTS: Clinical & Translational Science. Dec2023, Vol. 16 Issue 12, p2494-2506. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.13624